image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CN
$ 0.429
-4.77 %
$ 8.9 M
Market Cap
None
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one SISI stock under the worst case scenario is HIDDEN Compared to the current market price of 0.429 USD, Shineco, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one SISI stock under the base case scenario is HIDDEN Compared to the current market price of 0.429 USD, Shineco, Inc. is HIDDEN

This DCF valuation model was last updated on Jun, 6, 2025.

The intrinsic value of one SISI stock under the best case scenario is HIDDEN Compared to the current market price of 0.429 USD, Shineco, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart SISI

image
$5.0$5.0$4.5$4.5$4.0$4.0$3.5$3.5$3.0$3.0$2.5$2.5$2.0$2.0$1.5$1.5$1.0$1.0$0.5$0.5$0.0$0.015 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '2515 May15 MayJun '25Jun '25
FINANCIALS
9.8 M REVENUE
1680.61%
-17.1 M OPERATING INCOME
-94.87%
-22.4 M NET INCOME
-109.59%
-3.93 M OPERATING CASH FLOW
27.09%
-21 M INVESTING CASH FLOW
-2030.04%
11 M FINANCING CASH FLOW
145.54%
41 K REVENUE
-98.66%
-3.76 M OPERATING INCOME
-42.52%
2.64 M NET INCOME
215.35%
5.48 M OPERATING CASH FLOW
1006.90%
23 M INVESTING CASH FLOW
6178.14%
-19.9 M FINANCING CASH FLOW
-2691.87%
Balance Sheet Shineco, Inc.
image
Current Assets 20.9 M
Cash & Short-Term Investments 366 K
Receivables 1.22 M
Other Current Assets 19.3 M
Non-Current Assets 63.3 M
Long-Term Investments 0
PP&E 6.43 M
Other Non-Current Assets 56.8 M
22.95 %7.63 %67.53 %Total Assets$84.2m
Current Liabilities 27.6 M
Accounts Payable 813 K
Short-Term Debt 19.6 M
Other Current Liabilities 7.11 M
Non-Current Liabilities 20 M
Long-Term Debt 10 M
Other Non-Current Liabilities 10 M
41.26 %14.94 %21.04 %21.05 %Total Liabilities$47.6m
EFFICIENCY
Earnings Waterfall Shineco, Inc.
image
Revenue 9.8 M
Cost Of Revenue 8.92 M
Gross Profit 882 K
Operating Expenses 17.9 M
Operating Income -17.1 M
Other Expenses 5.38 M
Net Income -22.4 M
10m10m5m5m00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)(25m)(25m)10m(9m)882k(18m)(17m)(5m)(22m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
9.00% GROSS MARGIN
9.00%
-174.11% OPERATING MARGIN
-174.11%
-229.03% NET MARGIN
-229.03%
-86.34% ROE
-86.34%
-26.67% ROA
-26.67%
-21.88% ROIC
-21.88%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Shineco, Inc.
image
15m15m10m10m5m5m00(5m)(5m)(10m)(10m)(15m)(15m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -22.4 M
Depreciation & Amortization 4.99 M
Capital Expenditures -265 K
Stock-Based Compensation 2.87 M
Change in Working Capital 222 K
Others -967 K
Free Cash Flow -4.2 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Shineco, Inc.
image
SISI has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 9
6. Ownership
Insider Ownership Shineco, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Shineco Announces Acquisition of Medical Device Company The Acquisition is Expected to Create Immediate Synergies with the Company's Existing Medical Device Business  BEIJING, March 25, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on March 20, 2025, Shineco Life Science Group Hong Kong Co., Limited (“Shineco Life Science”), a subsidiary of the Company, entered into a Stock Purchase Agreement (“SPA”) with Yi Yang (the “Seller”), for 75% of an equity interest in FuWang (HK) International Company Limited (“FuWang Company”). The Seller is the current and only shareholder of FuWang Company, which specializes in the R&D, manufacturing, and commercialization of medical devices. globenewswire.com - 2 months ago
Future FinTech Announces the Appointment of Hu Li as the New CEO NEW YORK , Aug. 9, 2024 /PRNewswire/ -- Future Fintech Group Inc. (NASDAQ: FTFT), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and digital technology service provider, today announced that its Board of Directors (the "Board") approved the appointment of Mr. Hu Li as Chief Executive Officer ("CEO"), President and a member of the Board of the Company, effective August 5, 2024. prnewswire.com - 10 months ago
Shineco Announces Closing of $2 Million Underwritten Public Offering Beijing, July 15, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the closing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 280,374 shares of common stock at the public offering price per share, less the underwriting discounts to cover over-allotments, if any. globenewswire.com - 11 months ago
Why Is Shineco (SISI) Stock Down 54% Today? Shineco (NASDAQ: SISI ) stock is falling hard on Friday after the agricultural produce company announced the pricing of a public offering for its shares. This public offering has Shineco selling 1,869,160 shares of SISI stock for $1.07 each. investorplace.com - 11 months ago
Shineco Announces Pricing of $2 Million Underwritten Public Offering Beijing, July 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the pricing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 280,374 shares of common stock at the public offering price per share, less the underwriting discounts to cover over-allotments, if any. The offering is expected to close on July 15, 2024, subject to satisfaction of customary closing conditions. globenewswire.com - 11 months ago
Shineco Announces Proposed Underwritten Public Offering Beijing, July 11, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced it has commenced an underwritten public offering of shares of its common stock and pre-funded warrants to purchase its shares of common stock. All of the shares of common stock and pre-funded warrants and the shares of common stock underlying the pre-funded warrants are being offered by the Company. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. globenewswire.com - 11 months ago
Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that on June 5, 2024, the Company received a formal notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The notice indicated that as a result of the closing bid price of the Company's common stock having been at least $1.00 per share for the period of 10 consecutive business days, from May 20, 2024 through June 4, 2024, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and advised that this matter is now closed. globenewswire.com - 11 months ago
Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of $7.0 Million BEIJING, June 24, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on June 20, 2024, the Company entered into a Securities Purchase Agreement (the “SPA”) with certain non-U.S. investors (each individually, a “Purchaser,” and collectively, the “Purchasers”). Pursuant to the SPA, the Company will issue up to 1,400,000 shares of its common stock (the “Shares”) to the Purchasers in a private placement financing transaction (the “Offering”) at an offering price of $5.00 per share. The gross proceeds of the Offering are expected to be approximately $7,000,000, before the deduction of customary expenses. The Purchasers are a former related party of the Company, who agreed to purchase 1,000,000 shares of common stock, a management member of the Company, who agreed to purchase 200,000 shares of common stock, and an individual investor who agreed to purchase 200,000 shares of common stock. The Offering is expected to close, and the Shares are expected to be issued, on or about July 31, 2024. globenewswire.com - 11 months ago
Shineco Enters into a Letter of Intent with Meitong Technology to Address China's Aging Population BEIJING, June 20, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDA: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 18, 2024, it entered into an Investment Letter of Intent (the “Investment LOI”) with Beijing Oriental Meitong Technology Co., Ltd. (“Meitong Technology”) whereby Shineco intends to invest $20 million in Meitong Technology in exchange for 80% of Meitong Technology's shares. The Company believes that the acquisition of equity in Meitong Technology will add to the Company's core competencies and result in operating synergies that will enhance the Company's value proposition. globenewswire.com - 11 months ago
Shineco Enters into an Agreement with Turing Video to Jointly Develop Intelligent Health Care Products Beijing, June 17, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 14, 2024, its 51% owned subsidiary, Shangkang Life Science and Technology (Jiangsu) Co., Ltd. (“Shangkang Life Science”) entered into a Strategic Cooperation Framework Agreement (“the Agreement”) with Turing Video (Shenzhen) Co., Ltd (“Turing Video”) to jointly develop a series of smart medical products and introduce their biotechnology and other innovative health solutions to the healthcare market. globenewswire.com - 1 year ago
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session Shares of Virios Therapeutics, Inc. VIRI fell sharply during Monday's session after the company priced a $1.7 million public offering of 8.5 million shares of common stock at $0.20 per share. Virios Therapeutics shares dipped 47.6% to $0.1850 on Monday. Here are some other stocks moving in today’s mid-day session. MultiMetaVerse Holdings Limited MMV shares jumped 224% to $2.01. MultiMetaVerse Holdings signed a non-binding term sheet to acquire 100% of Bowong Technology (Shenzhen) Co., Ltd. and its subsidiaries. GT Biopharma, Inc. GTBP rose 146% to $7.64. GT Biopharma, last week, posted a narrower-than-expected quarterly loss. Tantech Holdings Ltd TANH jumped 89.8% to $1.2501. Faraday Future Intelligent Electric Inc. FFIE shares gained 62.1% to $1.6701. Faraday Future Intelligent Electric is scheduled to report its fourth quarter and full year 2023 results after the closing bell on Tuesday, May 28. CN Energy Group. Inc. CNEY surged 58% to $1.0501. Scorpius Holdings, Inc. SCPX gained 57.8% to $0.1635. Scorpius, last week, announced closing of public offering. NKGen Biotech, Inc. NKGN rose 46% to $1.6250 after the company’s SNK01 NK Cell Therapy was cleared to begin a Phase 2 trial in Alzheimer’s disease. Bruush Oral Care Inc. BRSH jumped 41% to $0.1658. Rekor Systems, Inc. REKR gained 36% to $1.80 after the company announced a partnership with MS2. MIRA Pharmaceuticals, Inc. MIRA gained 34.3% to $0.8866 after the company said it has advanced new preclinical studies using Ketamir-2 towards clinical development. Scilex Holding Company SCLX gained 34% to $1.21. Hims & Hers Health, Inc. HIMS rose 30.5% to $19.01 after the company announced the addition of GLP-1 injections to its weight loss portfolio. BYND Cannasoft Enterprises Inc. BCAN surged 29.5% to $1.4250. Cheetah Mobile Inc. CMCM gained 24.3% to $5.70. Concord Medical Services Holdings Limited CCM jumped 23% to $0.6188. Wix.com Ltd. WIX rose 21.6% to $164.94 as the company posted upbeat results for its first quarter and raised its 2024 forecast on Monday. Sintx Technologies, Inc. SINT shares rose 21.1% to $0.1029 after dipping over 39% on Friday. Sutro Biopharma, Inc. STRO climbed 17.6% to $4.7150. PTC Therapeutics, Inc. PTCT jumped 17.2% to $38.78 after the company announced the European Commission has returned the Translarna opinion to the CHMP for re-evaluation. Cue Health Inc. HLTH gained 17.1% to $0.1128 after dipping around 18% on Friday. Cue Health, last week, announced that it voluntarily and temporarily paused sales and distribution of its EUA COVID-19 Test Cartridge. NextDecade Corporation NEXT climbed 16% to $8.10 after ADNOC announced it secured an equity position and LNG offtake agreement in NextDecade’s Rio Grande LNG project. NuScale Power Corporation SMR rose 15.5% to $7.29. VinFast Auto Ltd. VFS gained 15% to $5.61. Crown ElectroKinetics Corp. CRKN shares rose 14.8% to $0.1964 after falling around 29% on Friday. Tellurian Inc. TELL gained 14% to $0.5870. Shineco, Inc. SISI shares climbed 10.2% to $1.09 after jumping 19% on Friday. Shineco recently announced that its subsidiaries Fuzhou Medashan Biotechnology and Kaifeng Yixi Biotechnology invented a new natural active water-soluble product. Independent Bank Group, Inc. IBTX gained 8.5% to $47.69 after SouthState announced it will acquire the company. Doximity, Inc. DOCS surged 5.1% to $29.46. Akoustis Technologies, Inc. AKTS fell 53.8% to $0.1647 after Qorvo won a jury verdict against the company in a trade secret misappropriation and patent infringement case. Cheetah Net Supply Chain Service Inc. CTNT declined 48% to $5.61. FLJ Group Limited FLJ shares fell 44.5% to $0.86 after surging 224% on Friday. Jaguar Health, Inc JAGX fell 39.8% to $0.1557 after the company announced a 1-for-60 reverse stock split. Fangdd Network Group Ltd. DUO declined 38% to $1.04. Jeffs’ Brands Ltd JFBR shares declined 35.8% to $0.4189 after jumping 109% on Friday. DermTech, Inc. DMTK fell 33.8% to $0.3302. CervoMed Inc. CRVO declined 25.3% to $17.99. CervoMed named William Elder as Chief Financial Officer, effective June 1. Barnes & Noble Education, Inc. BNED dipped 22.6% to $0.3482. Akanda Corp. AKAN shares fell 22.3% to $0.1339 following a 30% surge on Friday. iPower Inc. IPW shares fell 20.8% to $2.29 after jumping 98% on Friday. iPower, last week, reported better-than-expected third-quarter financial results. Nature’s Miracle Holding Inc. NMHI declined 19.9% to $0.5396. Nature’s Miracle mutually agreed to terminate plan to merge with Agrify Corp. Li Auto Inc. LI fell 12.6% to $21.74 after the company reported worse-than-expected first-quarter results and issued second-quarter guidance. GameStop Corp. GME declined 10% to $19.99. Oklo Inc. OKLO fell 8.6% to $8.23. IGM Biosciences, Inc. IGMS declined 8.2% to $8.46. Cemtrex, Inc. CETX shares fell 7.6% to $0.45 after climbing 49% on Friday. Cemtrex, last week, posted a wider quarterly loss. The Beauty Health Company SKIN declined 5.8% to $2.58. Inovio Pharmaceuticals, Inc. INO fell 5.6% to $11.33. ATRenew Inc. RERE shares fell 4.3% to $2.71 after reporting weak quarterly earnings. Now Read This: How To Earn $500 A Month From Lowe’s Stock Ahead Of Q1 Earnings Report © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. http://feeds.benzinga.com - 1 year ago
Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry BEIJING , May 1, 2024 /PRNewswire/ -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that its subsidiaries Fuzhou Medashan Biotechnology Co., Ltd. and Kaifeng Yixi Biotechnology Co., Ltd. prnewswire.com - 1 year ago
8. Profile Summary

Shineco, Inc. SISI

image
COUNTRY CN
INDUSTRY Drug Manufacturers - Specialty & Generic
MARKET CAP $ 8.9 M
Dividend Yield 0.00%
Description Shineco, Inc. engages in processing and distributing specialized fabrics, textiles, and other byproducts derived from an indigenous Chinese plant Apocynum Venetum in the People's Republic of China. The company's specialized fabrics, textiles, and other byproducts are specialized textile and health supplement products to incorporate traditional Eastern medicines with various scientific methods. It also grows and cultivates yew trees, fast-growing bamboo willows, and scenic greening trees; and provides logistic services for agricultural products. The company is headquartered in Beijing, the People's Republic of China.
Contact North Tower, Zhengda Center, Beijing, 100020 https://www.biosisi.com
IPO Date Sept. 28, 2016
Employees 119
Officers Mr. Sai Wang Chief Financial Officer & Director Mr. Chi Keung Yan Chief Strategy Officer Ms. Jennifer Zhan Chief Executive Officer & Executive Director Ms. Wang Xiaohui Executive President Dr. Fenming Liu Chief Scientist Mr. Qiyin Sun Chief Medical Consultant Mr. Xiqiao Liu Chief Operating Officer & Executive Director